Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac)

University of Saskatchewan, Saskatoon, Saskatchewan
Area(s) of Expertise

VIDO-InterVac is one of Canada’s premier research institutes, with more than 35 years of experience in infectious disease research and vaccine development for animals and humans. VIDO-InterVac has more than 150 personnel and some of the world’s most advanced containment infrastructure, including containment level 2 and level 3 animal housing and laboratories, a select agent lab, an aerobiology challenge unit, and a 160-acre containment level 2 research station. The unique $140-million large animal containment level 3 laboratory became operational in 2013. VIDO-InterVac can complete multiple stages of vaccine development including pre-clinical trials for human vaccines and full regulatory and efficacy trials for animal vaccines.

What the facility does

Vaccine development and testing, containment 2 and 3 infectious disease research, large animal models of disease, preclinical trials, regulatory trials.

Research Services

Pathogenomics, proteomics, metabolomics, kinomics, antigen identification, vaccine development, vaccine formulation and delivery, animal disease models (containment 2 and 3), preclinical vaccine testing (human), regulatory vaccine testing (animals)

Sectors of Application
  • Defense and security industries
  • Fisheries and aquaculture
  • Health care and social services

Name of specialized lab

Name of equipment

Description of function



Level 2

100,000 square feet of level 2 lab space and additional 20,000 square feet of level 2 animal isolation

Level 3

18 containment level 3 animal suites and 6 containment level 3 laboratories.  Animal suites can hold all species including up to 160 cattle under CL3.

Research station

160-acre Research Station

Research station certified to containment level 2 able to conduct large animal studies including efficacy trials on horses and cattle.

VIDO-InterVac – CL3 aerobiology lab

Madison Chamber, fully suited

Fully suited lab for aerobiology challenge experiments including Canada’s only Madison chamber for aerobiology challenge experiments.

VIDO-InterVac – select agent lab

Class 3 Glovebox

Provides infrastructure required to work with select agents as qualified by the Centers for Disease Control.

  • Bill & Melinda Gates Foundation
  • Boehringer Ingelheim Vetmedica
  • Canadian Centre for Vaccinology
  • Cangene Corporation
  • Centre for Drug Research and Development
  • CEVA
  • Department of National Defence
  • Elanco
  • Health Sciences North
  • International Livestock Research Institute
  • International Vaccine Institute
  • Kenyan Agricultural and Livestock Research Organization
  • Maple Leaf Foods
  • Meadow Ridge Enterprises
  • Merial Limited
  • National Veterinary Research and Quarantine Service
  • Novartis Animal Health
  • Pan-Provincial Vaccine Enterprise
  • Prevtec Microbia
  • Telesta
  • World Health Organization (WHO)



Funding awarded to develop vaccines for bovine tuberculosis and Johne’s disease’s-disease

Government of Canada announces funding to enhance influenza vaccine research and development

Federal Regulators Give InterVac Stamp of Approval

U of S, Kenyan and Ethiopian scientists partner on $5.3 million in projects to combat hunger

Saving Lives Through Vaccine Research

U of S International Vaccine Centre Celebrates Grand Opening